β-catenin and Her2/neu expression in rectal cancer: association with histomorphological response to neoadjuvant therapy and prognosis

被引：0
|
作者：
Uta Drebber
Martin Madeja
Margarete Odenthal
Inga Wedemeyer
Stefan P. Mönig
Jan Brabender
Elfriede Bollschweiler
Arnulf H. Hölscher
Paul M. Schneider
Hans P. Dienes
Daniel Vallböhmer
机构：
[1] University Hospital Cologne,Institute of Pathology
[2] University Hospital Cologne,Department of General, Visceral and Cancer Surgery
[3] University Hospital Zurich,Department of Visceral and Transplantation Surgery
来源：
International Journal of Colorectal Disease | 2011年 / 26卷
关键词：
Rectal cancer; Neoadjuvant therapy; Response prediction; Prognosis; β-catenin; Her2/neu;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] HER2 immunohistochemistry staining positivity is strongly predictive of tumor response to neoadjuvant chemotherapy in HER2 positive breast cancer
    Zhao, Jing
    Krishnamurti, Uma
    Zhang, Chao
    Meisel, Jane
    Wei, Zhimin
    Suo, Aili
    Aneja, Ritu
    Li, Zaibo
    Li, Xiaoxian
    PATHOLOGY RESEARCH AND PRACTICE, 2020, 216 (11)
  • [42] Serum HER2 levels predict treatment efficacy and prognosis in patients with HER2-positive breast cancer undergoing neoadjuvant treatment
    Zuo, Wen-Jia
    He, Min
    Zheng, Hui
    Liu, Yin
    Liu, Xi-Yu
    Jiang, Yi-Zhou
    Wang, Zhong-Hua
    Lu, Ren-Quan
    Shao, Zhi-Ming
    GLAND SURGERY, 2021, 10 (04) : 1300 - 1314
  • [43] Biology, prognosis and response to therapy of breast carcinomas according to HER2 score
    Menard, S.
    Balsari, A.
    Tagliabue, E.
    Camerini, T.
    Casalini, P.
    Bufalino, R.
    Castiglioni, F.
    Carcangiu, M. L.
    Gloghini, A.
    Scalone, S.
    Querzoli, P.
    Lunardi, M.
    Molino, A.
    Mandara, M.
    Mottolese, M.
    Marandino, F.
    Venturini, M.
    Bighin, C.
    Cancello, G.
    Montagna, E.
    Perrone, F.
    De Matteis, A.
    Sapino, A.
    Donadio, M.
    Battelli, N.
    Santinelli, A.
    Pavesi, L.
    Lanza, A.
    Zito, F. A.
    Labriola, A.
    Aiello, R. A.
    Caruso, M.
    Zanconati, F.
    Mustacchi, G.
    Barbareschi, M.
    Frisinghelli, M.
    Russo, R.
    Carrillo, G.
    ANNALS OF ONCOLOGY, 2008, 19 (10) : 1706 - 1712
  • [44] Cancer Vaccines Targeting HER2/neu for Early Breast Cancer
    Ryu, Woo Sang
    Son, Gil Soo
    JOURNAL OF BREAST CANCER, 2010, 13 (01) : 5 - 13
  • [45] Role of HER2neu expression in gastric cancer
    Sukanya, J. S.
    Raj, Pavithra Vittal
    Thanka, J.
    INDIAN JOURNAL OF PATHOLOGY AND MICROBIOLOGY, 2021, 64 (01) : 58 - 64
  • [46] Clinical importance of discordance of hormone receptors and Her2/neu status after neoadjuvant chemotherapy in breast cancer
    Ustaalioglu, Bala Basak Oven
    Vardar, Fugen Aker
    Bilici, Ahmet
    Gurleyik, Gunay
    Erkol, Burcak
    Kefeli, Umut
    Aliustaoglu, Mehmet
    JOURNAL OF BUON, 2014, 19 (04): : 879 - 886
  • [47] Pathologic complete response to neoadjuvant anti-HER2 therapy is associated with HER2 immunohistochemistry score in HER2-positive early breast cancer
    Chen, Hai-Long
    Chen, Qiang
    Deng, Yong-Chuan
    MEDICINE, 2021, 100 (44)
  • [48] Correlation of HER2 Expression with Clinicopathological Characteristics and Prognosis in Resectable Gastric Cancer
    Otsu, Hajime
    Oki, Eiji
    Ikawa-Yoshida, Ayae
    Kawano, Hiroyuki
    Ando, Koji
    Ida, Satoshi
    Kimura, Yasue
    Aishima, Shinichi
    Saeki, Hiroshi
    Morita, Masaru
    Kohnoe, Shunji
    Oda, Yoshinao
    Maehara, Yoshiniko
    ANTICANCER RESEARCH, 2015, 35 (04) : 2441 - 2446
  • [49] HER-2/neu as a predictive marker of response to breast cancer therapy
    Pegram, MD
    Pauletti, G
    Slamon, DJ
    BREAST CANCER RESEARCH AND TREATMENT, 1998, 52 (1-3) : 65 - 77
  • [50] Her-2/neu as a Predictive Marker of Response to Breast Cancer Therapy
    Mark D. Pegram
    Giovanni Pauletti
    Dennis J. Slamon
    Breast Cancer Research and Treatment, 1998, 52 : 65 - 77
12345